Archive for the ‘Viruses’ Category

CDC Says Tick & Mosquito Infections Spreading Rapidly

https://www.nytimes.com/2018/05/01/health/ticks-mosquitoes-diseases.html

Tick and Mosquito Infections Spreading Rapidly, C.D.C. Finds

More Americans are living in wooded suburbs near deer, which carry the ticks that spread Lyme disease, anaplasmosis, Rocky Mountain spotted fever, babesiosis, rabbit fever and Powassan virus.  Credit Scott Camazine/Science Source

The number of people who get diseases transmitted by mosquito, tick and flea bites has more than tripled in the United States in recent years, federal health officials reported on Tuesday. Since 2004, at least nine such diseases have been newly discovered or introduced into the United States.

Warmer weather is an important cause of the surge in cases reported to the Centers for Disease Control and Prevention, according to the lead author of a study in the agency’s Morbidity and Mortality Weekly Report.

But the author, Dr. Lyle R. Petersen, the agency’s director of vector-borne diseases, repeatedly declined to connect the increase to the politically fraught issue of climate change, and the report does not mention either climate change or global warming.

Many other factors are at work, he emphasized, while noting that “the numbers on some of these diseases have gone to astronomical levels.”

C.D.C. officials called for more support for state and local health departments. Local agencies “are our first line of defense,” said Dr. Robert Redfield, the C.D.C.’s new director. “We must enhance our investment in their ability to fight these diseases.”

 Although state and local health departments get brief infusions of cash during scares like the 2016 Zika epidemic, they are chronically underfunded. A recent survey of mosquito control agencies found that 84 percent needed help with basics like surveillance and pesticide-resistance testing, Dr. Petersen said.

While the C.D.C. did not suggest that Americans drop plans for playing outdoors or lying in hammocks this summer, Dr. Redfield emphasized that everyone — especially children — needed to protect themselves against tick and mosquito bites.

Between 2004 and 2016, about 643,000 cases of 16 insect-borne illnesses were reported to the C.D.C. — 27,000 a year in 2004, rising to 96,000 by 2016. (The year 2004 was chosen as a baseline because the agency began requiring more detailed reporting then.)

The real case numbers were undoubtedly far larger, Dr. Petersen said. For example, the C.D.C. estimates that about 300,000 Americans get Lyme disease each year, but only about 35,000 diagnoses are reported.

The study did not delve into the reasons for the increase, but Dr. Petersen said it was probably caused by many factors, including two related to weather: Ticks thriving in regions previously too cold for them, and hot spells triggering outbreaks of mosquito-borne diseases.

Other factors, he said, include expanded human travel, suburban reforestation and a dearth of new vaccines to stop outbreaks.

In an interview, Dr. Petersen said he was “not under any pressure to say anything or not say anything” about climate change and that he had not been asked to keep mentions of it out of the study.

More jet travel from the tropics means that previously obscure viruses like dengue and Zika are moving long distances rapidly in human blood. (By contrast, malaria and yellow fever are thought to have reached the Americas on slave ships three centuries ago.)

A good example, Dr. Petersen said, was chikungunya, which causes joint pain so severe that it is called “bending-up disease.”

In late 2013, a Southeast Asian strain arrived on the Dutch Caribbean island of St. Maarten, its first appearance in this hemisphere. Within one year, local transmission had occurred everywhere in the Americasexcept Canada, Chile, Peru and Bolivia.

Tickborne diseases, the report found, are rising steadily in the Northeast, the Upper Midwest and California. Ticks spread Lyme disease, anaplasmosis, babesiosis, Rocky Mountain spotted fever, rabbit fever, Powassan virus and other ills, some of them only recently discovered.

Ticks need deer or rodents as their main blood hosts, and those have increased as forests in suburbs have gotten thicker, deer hunting has waned, and rodent predators like foxes have disappeared.

(A century ago, the Northeast had fewer trees than it now does; forests made a comeback as farming shifted west and firewood for heating was replaced by coal, oil and gas.)

Most disease outbreaks related to mosquitoes since 2004 have been in Puerto Rico, the Virgin Islands and American Samoa. But West Nile virus, which arrived in 1999, now appears unpredictably across the country; Dallas, for example, saw a big outbreak in 2012.

For most of these diseases, there are no vaccines and no treatment, so the only way to stop outbreaks is through mosquito control, which is expensive and rarely stops outbreaks. Miami, for instance, was the only city in the Western Hemisphere to halt a Zika outbreak with pesticides.

The only flea-borne disease in the report is plague, the bacterium responsible for the medieval Black Death. It remains rare but persistent: Between two and 17 cases were reported from 2004 to 2016, mostly in the Southwest. The infection can be cured with antibiotics.

Dr. Nicholas Watts, a global health specialist at University College London and co-author of a major 2017 report on climate change and health, said warmer weather is spreading disease in many wealthy countries, not just the United States.

In Britain, he said, tick diseases are expanding as summers lengthen, and malaria is becoming more common in the northern reaches of Australia.

But Paul Reiter, a medical entomologist at the Pasteur Institute, has argued that some environmentalists exaggerate the disease threats posed by climate change.

The 2003-2014 period fell during what he described as “a pause” in global warming, although the notion of a long trend having pauses is disputed.

Also, disease-transmission dynamics are complicated, and driven by more than temperature. For example, transmission of West Nile virus requires that certain birds be present, too.

In the Dust Bowl years of the 1930s, St. Louis encephalitis, a related virus, surged, “and it looked like climate issues were involved,” Dr. Reiter said. But the surge turned out to depend more on varying hot-cold and wet-dry spells and the interplay of two different mosquito species. St. Louis encephalitis virtually disappeared, weather notwithstanding.

“It’s a complicated, multidimensional system,” he said.

A. Marm Kilpatrick, a disease ecologist at the University of California, Santa Cruz, said many factors beside hot weather were at work, including “a hump-shaped relationship between temperature and transmission potential.”

Warm weather helps mosquitoes and ticks breed and transmit disease faster, he explained. But after a certain point, the hotter and drier it gets, the more quickly the pests die. So disease transmission to humans peaks somewhere between mildly warm and hellishly hot weather.

Experts also pointed out that the increase in reports of spreading disease may have resulted partially from more testing.

Lyme disease made family doctors begin to suspect tick bites in patients with fevers. Laboratories began looking for different pathogens, especially in patients who did not have Lyme. That led to the discovery of previously unknown diseases.

**Comment**
I for one appreciate Peterson’s refusal to push the climate change model.  Finally, someone who refuses to fall for the bait.
While mosquitos are more dependent upon weather for survival, ticks are appearing nearly indestructible, but fire does kill them:  https://madisonarealymesupportgroup.com/2018/04/03/fire-good-news-for-tick-reduction/
Excerpt:
Ottmar Edenhofer, lead author of the IPCC’s fourth summary report released in 2007 candidly expressed the priority. Speaking in 2010, he advised, “One has to free oneself from the illusion that international climate policy is environmental policy. Instead, climate change policy is about how we redistribute de facto the world’s wealth.”

New Lyme Vaccine Pushed, Same Vaccine Corruption Revealed

http://healthimpactnews.com/2017/new-lyme-vaccine-pushed-same-vaccine-corruption-revealed/  April 28, 2018

New Lyme Vaccine Pushed, Same Vaccine Corruption Revealed

Politics-lyme-disease

by Jefferey Jaxen
Health Impact News

Since the Flexner Report over a century ago, politics and business has solely directed the progression of establishment health while true healing has taken a backseat. The National Childhood Vaccine Injury Act of 1986 added a new layer to the medical-industrial money game.

A result of the 1986 act was to give vaccine manufacturers legal protection from the harm caused by their products. It was at that moment two distinct directions emerged that would determine the future of medicine and further entrench an already failed healing paradigm.

First, vaccine manufacturers began to focus on shifting the industry to, now legally protected, vaccine-related products and interventions for diseases and ailments to maximize profits. Second, the American public was forced to bear the burden of an increasing vaccine schedule and experience limiting health freedom by policies enacted by pharmaceutical-lobbied politicians. The race was on to develop and approve vaccines for everything from cancers to sexually transmitted diseases.

In 2013 the US Centers for Disease Control and Prevention (CDC), proven to be an action arm for pharmaceutical companies, ‘revised’ its estimate of Lyme disease rates in the US saying there could be over 300,000 people infected. At that time, the CDC’s announcement coincided with the release of a new Lyme vaccine developed (and later abandoned) by Baxter Laboratories.

The agencies’ announcement also was followed by a media blitz that saw a New York Times (NYT) endorsement and call for doctors to petition the CDC to release the vaccine. The pro-vaccine NYT author’s primary position was executive adviser at the pharmaceutical firm Sanofi Pasteur. At the same time, the investigative journalism outlet truth-out.org released a story titled Lyme Disease Community Blows the Whistle on Corruption Within the CDC stating that:

Through documents obtained as a result of a Freedom of Information Act request, Stanford journalist Kris Newby uncovered news that a shadow group consisting of CDC employees and other researchers have significant commercial interests in Lyme disease tests and vaccines. A large percentage of government grants were given to these group members. Newby found that this group has been setting Lyme disease policy and a national research agenda without public oversight or transparency.

The CDC states that Lyme disease is one of the fastest growing vector-borne infections in the US and Congress made development of a new Lyme disease vaccine a funding priority in the 21st Century Cures Act passed at the end of 2016.

The agency appears to have only admitted the real number of people suffering from Lyme disease because there was money to be made and vaccines to be rolled out. It has been estimated that Lyme disease costs the US health care system about $2 billion a year to treat. Much like autism, fibromyalgia, and other disorders, establishment medicine, official government agencies, and insurance companies continue to purposely ignore fast growing and real epidemic-level health issues until they can make a buck off their cures or the lifelong management of the disorder/disease.

Despite a long absence of any official acknowledgement from the CDC, the general public has long-echoed the sentiments of Richard Horowitz, MD, author ofWhy Can’t I Get Better? Solving the Mystery of Lyme & Chronic Disease when he recently told Fox5 New York:

“There is not even a doubt that we are in the middle of a full-blown epidemic in the United States.”

In August 2016, Massachusetts proposed Bill H.4491 entitled An Act Relative to Expanded Access to Therapies for the Treatment of Lyme Disease that would allow long-term treatment of Lyme disease and demand insurance companies to cover experimental drugs as well, including for off-label use, as long as the drugs are approved (for any indication) by the Food and Drug Administration (FDA).

The orthodox medical community continues to rely on testing methods that miss or misdiagnose large percentages of patients. Their limited answers of heavy doses of antibiotic treatment and immune suppression in the patient often leads to a revolving door of symptom suppression and unpleasant side effects without elimination of the underlying disease.

When the Massachusetts Lyme Bill was filed in late summer of 2016, a group of doctors from Boston Children’s Hospital’s Division of Infectious Diseases wrote to legislative leaders warning:

Well-designed studies have shown that administration of additional or prolonged courses of antibiotics confers no benefit to patients who have had a standard course of accepted treatment for Lyme disease.

Fast forward to January 2017 when it was reported that the FDA has given the green light to test another Lyme disease vaccine on humans after two decades of failed attempts to develop an oxymoronic ‘safe vaccine’ to counter the disease. French biotech company Valneva said in their statement:

We are committed to finding ways to accelerate the clinical development path to licensure, given that we are conducting the only active vaccine program in the industry

The FDA granted a phase 1 clinical trial of the vaccine named VLA15-101 which means it’s being evaluated for safety — not how effective it is, or if it even works at all. If the phase 1 trials show the vaccine is safe to use in people, it will have to clear two other hurdles before Valneva could sell and market it: a phase 2 trial, which would test how well it works in preventing cases of Lyme disease, and a phase 3 trial, which more broadly tests effectiveness by using different dosages on larger and more diverse populations.

Meanwhile, Stanley A. Plotkin, an emeritus pediatrics professor at the University of Pennsylvania and Lyme disease vaccine advocate best explains the pharmaceutical hurdle profit takers and lobbied government officials face by stating in his recent New England Journal of Medicine editorial:

To promote the licensure of a new vaccine against Lyme disease, perhaps the greatest need is a concerted demand by the public health community, which would convince manufacturers that there is a market for such a vaccine…

For now the question appears, as Lyme vaccine testing continues in the background, how hard and loud will government agencies, pharmaceutical-funded corporate media organs, and industry-captured medical journals bang the drums to manufacture a consensus for a predictably unsafe and ineffective vaccine?

Dr. Paul Mead, chief of epidemiology and surveillance for the CDC’s Lyme disease program stated:

Primary prevention is something where we’re clearly losing the battle on…A safe and effective vaccine could help us turn the tide.

However, Dr. Mead has come under fire over the past few years as he appears to be using the CDC as a megaphone to cheerlead for a new Lyme vaccine. After public backlash to Dr. Mead’s lackluster and uninformed July 2016 interview on FOX5 New York, the news media’s Facebook page allowed Yale-trained Lyme disease expert Dr. Steven Phillips to methodically deconstruct the CDC doctor’s assertions.

According to a recent Business Insider article, 94% of all drugs that pass animal trials fail to pass in human clinical trials, while getting a treatment all the way through phase 3 trials can cost more than a billion dollars. Perhaps the Massachusetts Lyme Bill and others that may follow, the CDC’s continued calls for rapid answers to Lyme disease, and the editorials written by industry doctors may be a targeted narrative attempting to fast-track a vaccine that would have little success without such assistance.

It is important to understand that Lyme disease is commonly misdiagnosed and has symptoms that mirror vaccine injury and other disorders that target the neurological system. For those who currently suffer from Lyme disease, homeopathic medicine has continued to show promise yet has been virtually ignored by orthodox medicine.

Comment on this article at VaccineImpact.com.

**Comment**

Great reminder of the time-line of events.  These “well-designed studies” showing that extended antibiotics confers no benefit is a bunch of hog-wash.  Not only is this untrue for me, it’s untrue for many that I work with.  While it’s true, there are many other avenues of treatment needed for improvement (nutrition, proper sleep, pain management, psych help, immune building, etc.) reducing and sometimes eliminating pathogens altogether is important.  Antibiotics and other antimicrobials can do this.  Treatment; however, is often in the years, not days and months as most GP’s think.  One of the most experienced LLMD’s in Wisconsin has stated that in the 70’s, this illness was often effectively dealt with in months to 1 year but that now, for whatever reason, it’s taking 3-4 years (sometimes longer) of solid treatment. The author mentions homeopathy showing promise.  I’ve yet to see this information and personally didn’t notice one solid thing when taking them.  I’ve heard one practitioner state they helped her detox, but in and of themselves, I’d advise caution in using this as a solo treatment.  In fact, I’d caution against any treatment that is a mono-therapy.  In my experience, the wisest treatment is overlapping and uses many modalities.  We are fighting stealth pathogens – and often many of them that together take our bodies down, down to goblin town.  Assisting the immune system and detoxing are as important as killing but all need to be addressed.

For treatment options:  https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/

https://madisonarealymesupportgroup.com/2016/01/03/bartonella-treatment/

https://madisonarealymesupportgroup.com/2016/01/16/babesia-treatment/

https://madisonarealymesupportgroup.com/2016/02/07/mycoplasma-treatment/

https://madisonarealymesupportgroup.com/2016/03/08/anaplasmosis/

https://madisonarealymesupportgroup.com/2016/03/28/combating-viruses/

https://madisonarealymesupportgroup.com/2017/04/17/mast-cell-activation-syndrome-lymemsids/

https://madisonarealymesupportgroup.com/2018/03/05/how-proteolytic-enzymes-may-help-lyme-msids/

https://madisonarealymesupportgroup.com/2018/03/02/dmso-msm-for-lyme-msids/

For more on the Lyme Vaccine:  https://madisonarealymesupportgroup.com/2018/01/28/the-secret-x-files-the-untold-history-of-the-lymerix-vaccine/

https://madisonarealymesupportgroup.com/2017/09/07/20268/

https://madisonarealymesupportgroup.com/2017/01/26/lyme-vaccine-to-be-tested-on-humans/

https://madisonarealymesupportgroup.com/2017/07/01/pbs-lyme-vaccine/

https://madisonarealymesupportgroup.com/2016/08/04/vaccine-injuries-and-the-lyme-connection/  The LYMEerix vaccine was manufactured with ‘outer surface protein A’ (OspA). OspA is fungal and therefore has an immunosuppressive effect – causing post-sepsis syndrome. People injected with this vaccine were effected similarly to those bitten by a tick -which injects spirochetes (toxic fungi). Ironically, this vaccine was making people sick with the exact thing it was supposed to prevent!

https://madisonarealymesupportgroup.com/2017/12/02/scottish-doctor-gives-insight-on-lyme-msids/ a number of young women who fell ill after their HPV vaccination, which seems to have stimulated a latent Lyme infection to reactivate.

https://madisonarealymesupportgroup.com/2016/04/24/gardasil-and-bartonella/ Asymptomatic girls after receiving Gardasil activated dormant Bartonella which was confirmed by testing.

EBV Protein Can Turn-on Genes for Autoimmune Diseases

https://www.nih.gov/news-events/news-releases/epstein-barr-virus-protein-can-switch-risk-genes-autoimmune-diseases

Monday, April 16, 2018

Epstein-Barr virus protein can “switch on” risk genes for autoimmune diseases

EBV may trigger some cases of lupus, say NIH-supported researchers.

Infection with Epstein-Barr virus (EBV), the cause of infectious mononucleosis, has been associated with subsequent development of systemic lupus erythematosus and other chronic autoimmune illnesses, but the mechanisms behind this association have been unclear. Now, a novel computational method shows that a viral protein found in EBV-infected human cells may activate genes associated with increased risk for autoimmunity. Scientists supported by the National Institute of Allergy and Infectious Diseases report their findings today in Nature Genetics.

“Many cases of autoimmune illness are difficult to treat and can result in debilitating symptoms. Studies like this are allowing us to untangle environmental and genetic factors that may cause the body’s immune system to attack its own tissues,” said NIAID Director Anthony S. Fauci, M.D.  “A better understanding of the complex causes of autoimmunity promises to lead to better treatment and prevention options.”

EBV infection is nearly ubiquitous in the human population worldwide. Most people acquire EBV in early childhood, experience no symptoms or only a brief, mild cold-like illness, and remain infected throughout their lives while remaining asymptomatic. When infection first occurs in adolescence or young adulthood, EBV can lead to a syndrome of infectious mononucleosis characterized by prolonged fever, sore throat, swollen lymph nodes and fatigue.  This syndrome, also known as “mono” or the “kissing disease,” generally resolves with rest and only rarely causes serious complications.

When EBV infects human immune cells, a protein produced by the virus — EBNA2 — recruits human proteins called transcription factors to bind to regions of both the EBV genome and the cell’s own genome. Together, EBNA2 and the human transcription factors change the expression of neighboring viral genes.

In the current study, the researchers found that EBNA2 and its related transcription factors activate some of the human genes associated with the risk for lupus and several other autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, type 1 diabetes, juvenile idiopathic arthritis and celiac disease.

Previous studies suggested that EBV infection may result in autoimmune diseases, particularly lupus.  In the current work, researchers led by John B. Harley, M.D., Ph.D., director of the Center for Autoimmune Genomics and Etiology (CAGE) at Cincinnati Children’s Hospital Medical Center, with his colleagues Matthew T. Weirauch, Ph.D., and Leah C. Kottyan, Ph.D., also of CAGE, wondered whether genetic analysis could further explain the relationship between EBV infection and lupus. Their team developed a new computational and biochemical technique known as the Regulatory Element Locus Intersection algorithm, or RELI. Sifting through and comparing a large collection of genetic and protein data from healthy individuals and those with autoimmune diseases, the team used RELI to identify regulatory regions in genes associated with the risk of developing lupus that also bound EBNA2 and its related transcription factors.

“We were surprised to see that nearly half of the locations on the human genome known to contribute to lupus risk were also binding sites for EBNA2,” said Dr. Harley. “These findings suggest that EBV infection in cells can actually drive the activation of these genes and contribute to an individual’s risk of developing the disease.”

In follow-up analyses, the investigators used RELI to probe regulatory genes associated with other autoimmune diseases and found that EBNA2 bound to genes associated with the risk for multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, type 1 diabetes, juvenile idiopathic arthritis and celiac disease.

“Because EBV is most often encountered in early childhood, avoiding infection is practically impossible,” said Daniel Rotrosen, M.D., director of the Division of Allergy, Immunology and Transplantation at NIAID. “However, now that we understand how EBV infection may contribute to autoimmune diseases in some people, researchers may be able to develop therapies that interrupt or reverse this process.”

Researchers note that EBV infection is not the only factor that contributes to the development of the seven autoimmune conditions discussed in the paper. Many of the regulatory genes that contribute to lupus and other autoimmune disorders did not interact with EBNA2, and some individuals with activated regulatory genes associated with disease risk do not develop disease.

NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH…Turning Discovery Into Health®

Reference

J Harley, et al. Transcription factors operate across disease loci, with EBNA2 implicated in immunity. Nature Genetics DOI: 10.1038/s41588-018-0102-3 (2018).

______________

**Comment**

Folks with Lyme/MSIDS have been misdiagnosed with EBV:  https://madisonarealymesupportgroup.com/2017/04/11/diagnosed-with-ebv-had-lyme/ and others have it as well as tick-borne infections.  The involvement with numerous viruses is quite common in patients as well.  https://madisonarealymesupportgroup.com/2016/03/28/combating-viruses/

https://madisonarealymesupportgroup.com/2017/07/14/another-dies-from-powassan/

https://madisonarealymesupportgroup.com/2018/04/08/novel-viruses-found-in-lone-star-american-dog-black-legged-ticks/

https://madisonarealymesupportgroup.com/2018/04/21/neurological-lyme-disease-what-you-need-to-know/  “Once microbes start becoming active, inflammation increases and immune functions are further compromised, establishing what I call Chronic Immune Dysfunction (CID). In its weakened state, the immune system allows reactivation of viruses such as Epstein Barr virus (EBV), Cytomegalovirus (CMV), and other similar viruses — all of which most people harbor in their tissues. These viruses are commonly associated with neuroinflammation, and they tend to complicate the picture of LNB.”

https://madisonarealymesupportgroup.com/2017/11/04/24514/  EBV a Key Player in Chronic Illness & Tips to Treat Reactivated EBV.

 

 

 

 

Neurological Lyme Disease: What You Need to Know

https://rawlsmd.com/health-articles/neurological-lyme-disease-what-you-need-to-know?Neurological Lyme Disease: What You Need to Know

Neurological Lyme Disease: What You Need to Know

by Dr. Bill Rawls
Posted 4/20/18

Lyme disease can manifest in a seemingly endless number of ways. While the spectrum of symptoms is similar for most sufferers, the worst of the bunch varies from person to person. And for those who have a predominance of neurological symptoms, the disease can feel especially debilitating and difficult to overcome.

That’s in large part because neurological Lyme — also referred to as Lyme neuroborreliosis (LNB) — is often confused with other serious neurological conditions such as multiple sclerosis and Parkinson’s Disease, which can be scary and overwhelming. And because most doctors lack an understanding of Lyme disease in general, and especially of Lyme associated with a predominance of neurological symptoms, LNB often goes unrecognized.

So how to know if the symptoms you’re experiencing do signify LNB, and where do you go from there to find relief? Keep reading for information that could provide the turning point in your recovery.

Understanding Symptoms of Neurological Lyme

Lyme neuroborreliosis is thought to occur in about 15% of Lyme disease cases — but a definite percentage is impossible to pin down. Everyone with Lyme disease experiences some neurological symptoms, but a specific composit of symptoms that constitute neurological Lyme is not well defined. Making matters worse, the Centers for Disease Control (CDC), does not recognize LNB as a separate entity, and it doesn’t acknowledge the existence of a chronic form of Lyme disease.

The most common initial symptom is neurogenic (nerve) pain that starts in the back and radiates down the legs. With that comes weakness, numbness, and tingling in the lower extremities.

Another common presenting symptom of LNB is facial nerve palsy (Bell’s palsy), which is characterized by temporary paralysis on one side of the face. Some people also experience sound sensitivity and discomfort in the ear on the paralyzed side, and if you’re unable to close that eye, dry eye can occur. Most people recover fully from Bell’s palsy, with improvement in the first few weeks and continuing for three to six months, but a minority of people have symptoms for life.

The transition from acute to chronic neurological symptoms is not well defined, and it varies widely from person to person. Many people don’t remember a tick bite and experience minimal acute symptoms. The range of symptoms includes both motor and sensory nerve deficits. On the list: headache, memory loss, brain fog, cognitive impairment, learning disability, anxiety, depression, limb pain, muscle weakness, and paresthesias (sensory loss and odd sensations on the skin).

Symptoms of LNB are thought to occur from infiltration of white blood cells — immune cells like lymphocytes and plasmocytes — into the white matter of the brain and the spinal cord, otherwise known as the central nervous system (CNS). This is associated with an increase in inflammatory immune messengers, called cytokines, in cerebrospinal fluid.

Loss of sensory and motor nerve function is thought to be related to demyelination of nerve fibers. Found in the brain and peripheral nervous system, nerve fibers are coated with a fatty substance called myelin. Myelin acts much like the plastic coating on a copper wire: it wraps around nerve fibers, thus preventing the nerve fibers from touching each other and “shorting out” when an electrical current passes through. If demyelination is severe enough, it can result in abnormal nerve conduction tests, similar to multiple sclerosis.

Treatment for neurological Lyme is highly controversial. The CDC recommends antibiotic therapy using doxycycline, cefuroxime, or amoxicillin, limited to 10-21 days for formally diagnosed Lyme disease only. Remember, they don’t define LNB as separate from Lyme disease, and so specific treatment recommendations are not provided. Notably, the CDC website also cites numerous scientific articles showing that long-term antibiotic treatment for Lyme disease is not efficacious.

Among physicians who do recognize and treat LNB, there is no absolute consensus on therapy. Some physicians recommend 1-3 months of combined intravenous antibiotic therapy, and some continue to treat patients as long as symptoms are present. Confusing matters more, some studies that suggest oral antibiotic therapy is as efficacious as intravenous antibiotics, but long term follow up for any therapy is limited.

Central to the confusion is the fact that understanding of LNB and Lyme disease in general is clouded by reductionist science — studying one variable in a vacuum, while ignoring all other potential influencing variables. The variable in this case: the microbe Borrelia burgdorferi, the primary pathogen behind Lyme.

An Alternative View of Neurological Lyme

Anyone struggling with Lyme knows that the disease isn’t caused by borrelia alone. Indeed, having coinfections with microbes other than borrelia is more common than not. The most common coinfections include mycoplasma, bartonella, chlamydia, babesia, anaplasma, ehrlichia, and rickettsia. And all of these pathogens have the potential to cause neuroinflammatory symptoms that are characteristic of LNB.

Though all of these microbes can be transmitted by ticks, they can also be transmitted by other routes. For instance, bartonella is most commonly spread by scratches and bites from dogs and cats. Babesia can be transmitted by ticks and mosquitos. And mycoplasma and chlamydia are most commonly spread by respiratory or sexual route.

Often called stealth microbes, these microbes share similar characteristics:

  • They often don’t cause significant symptoms at initial infection.
  • They infect white blood cells and quietly spread to all tissues throughout the body, including brain and nerve tissues.
  • They are able to generate inflammation to break down tissues and gain access to nutrients.
  • They are masters at manipulating the immune system.
  • They grow very slowly.
  • They occur in low concentrations in the body, allowing them to blend in with other microbes.

The stealth microbes we know about may be just scratching the surface — science uncovers new ones on a regular basis. Ticks and other biting insects can spread an enormous variety of microbes beyond the classic coinfections. Microbes can also be spread by oral routes, inhalation, intimate contact with other people, breaks in skin, and blood transfusions or contact with contaminated blood.

Some of these microbes are more concerning than others, but if your immune system functions are strong, you’ll never know they’re there. In other words, the chances that you’ve encountered and picked up a variety of stealth-type microbes at some point in your life are much higher than you might think. And you’ve likely carried them without even knowing it, because they can remain dormant in tissues for years without causing harm.

This is true even with borrelia: People suffering from chronic Lyme disease typically don’t become chronically ill immediately after a tick bite. Onset of illness can happen months or even years later — it is typically surrounded by a perfect storm of stress factors that come together to disrupt immune system functions.

I’ve often related it to a pot boiling over on the stove. If immune system functions are healthy, microbes can be present in tissues, but suppressed and not causing symptoms — the equivalent of a pot of water on the stove being kept at a low simmer. But if immune system functions become disrupted, the pot of water starts to boil.

Immune disruption is most often caused by a combination of chronic stress factors such as poor diet, exposure to toxic substances like mold toxins, and emotional or physical stress. Sometimes, the tipping point is the infection caused by microbes that are acquired from a tick bite. But most often, the microbes are already present in the host, and they only become ill when other stress factors accumulate in their lives.

No matter what the initiating cause, however, when the pot reaches a full boil, it’s no longer an infection with one microbe or even a few microbes. Instead, it’s a disruption of the entire microbiome.

Once microbes start becoming active, inflammation increases and immune functions are further compromised, establishing what I call Chronic Immune Dysfunction (CID). In its weakened state, the immune system allows reactivation of viruses such as Epstein Barr virus (EBV), Cytomegalovirus (CMV), and other similar viruses — all of which most people harbor in their tissues. These viruses are commonly associated with neuroinflammation, and they tend to complicate the picture of LNB.

Chronic Immune Dysfunction also allows opportunistic pathogens to flourish in the gut and elsewhere in the body. The inflammation they generate compromises the gut barrier, allowing microbes along with foreign proteins from food to pass into the bloodstream. This heightens systemic inflammation and can compromise the blood brain barrier, allowing microbes to pass into the brain and nervous system.

Making Connections to Clarify Diagnosis

Chronic Lyme disease shares many symptoms with other chronic illnesses. This is especially true of Lyme neuroborreliosis and chronic neuroinflammatory illnesses such as multiple sclerosis, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and traumatic brain injury.

Not surprisingly, new sophisticated methods of microbial detection are showing potential links between these neuroinflammatory illnesses and many of the microbes associated with chronic Lyme disease.

For instance, both mycoplasma and chlamydia have been closely linked to multiple sclerosis. Mycoplasma, borrelia, and chlamydia have been associated with demyelination. Parkinson’s and ALS have been linked to borrelia and other microbes commonly associated with Lyme disease. Borrelia and other stealth pathogens have been found in the brains of patients who died of Alzheimer’s disease.

The connections go well beyond Lyme disease microbes. Two recent studies are shedding new light on how closely disruptions in the microbiome are linked to neuroinflammation. One, published in Frontiers of Aging Neuroscience, evaluated the presence of microbes in the autopsied brains of deceased Alzheimer’s patients. The other, published in Scientific Reports, evaluated the presence of microbes in the autopsied brains of people who had died of multiple sclerosis.

Both studies used a new type of microbial testing called 16S ribosomal RNA gene sequencing, which enabled scientists to separate human cells from microbial ones, and positively identify microbes. They found that not only were microbes present in diseased brains in both studies, but the magnitude of their presence was astounding: The entire microbiome, with a full spectrum of microbes from the gut, mouth, and skin, were represented.

Equally interesting, the control brains from people who had died of other causes also had a full spectrum of microbes present. The main difference? Diseased brains had a much higher concentration of microbes, and a greater prevalence of microbes with higher potential to cause inflammation.

I believe these studies are landmark, because they illustrate the close ties between disruption of the microbiome and chronic neuroinflammatory illnesses. Considered in this light, they also highlight the potential connection between Lyme neuroborreliosis and other neuroinflammatory diseases. This would suggest that Chronic Immune Dysfunction is central to the equation, allowing opportunistic pathogens of many varieties (not just those from ticks) to flourish, cause system inflammation, and create a vicious cycle of unending misery.

Ultimately, the type of illness a person might end up with depends on three key things: how the immune-disrupting factors come together; the types of pathogens they accumulated through life; and genetics (some people are more genetically at risk than others for these types of illnesses). Therefore, targeting individual microbes with antibiotic therapy alone is unlikely to restore normal health.

So what does restore well-being? Therapy that comprehensively addresses chronic immune dysfunction and widespread disruption of the microbiome.

How to Recover from Neurological Lyme

When you’re suffering from debilitating symptoms of neurological Lyme, it’s tempting to seek out medications that promise fast relief. Unfortunately, the place for drug therapy in chronic neuroinflammatory illnesses is limited. In fact, because neuroinflammation is so complex, targeted synthetic drug therapy often disrupts the healing process.

Many medications suppress or disrupt immune system functions and inhibit deep sleep, which is absolutely essential for recovery. Anti-inflammatory drugs, including steroids and nonsteroidal anti-inflammatory agents like ibuprofen and naproxen, disrupt immune functions and inhibit healing.

These drugs have also been shown to inhibit clearance of beta amyloid, a proteinaceous substance associated with neuroinflammatory disorders that is the hallmark identifying factor of Alzheimer’s disease. Though short-term use of antibiotic therapy has shown limited benefit in some cases of dementia and MS, tolerance to therapy and relapse are inevitable with long term use of synthetic antibiotics.

This makes sense when you consider that LNB and other neuroinflammatory conditions are primarily associated with disruptions in the balance of the entire microbiome and chronic immune dysfunction — as opposed to infections with specific pathogens. So while antibiotics initially suppress microbes in general, with extended use, pathogens arise in the gut and skin, gut and brain barriers are further compromised, and immune functions are further depressed, thus enhancing illness.

Instead, to overcome Lyme neuroborreliosis, you must approach it like you would another neuroinflammatory condition. The key components of recovery from any type of neuroinflammatory condition include:

  • Reducing both systemic and nervous system inflammation
  • Promoting optimal blood flow and vascular function
  • Restorating normal sleep
  • Supporting the immune system and restoring homeostasis
  • Enhancing healing and restoration of normal gut and brain barriers
  • Restoring balance to the microbiome of the gut and the entire body

That might sound like a lot, but in fact, finding lasting relief from neurological Lyme calls for a more measured, lifestyle approach — one that’s supportive of your immune system so that you’re enabling your body to fight its own battles. Here, the five steps for putting this approach into motion.

1. Nourish your body

Optimal nourishment is essential for reducing neuroinflammation. An anti-inflammatory diet is especially rich in fresh vegetables, healthful fats, and anti-inflammatory protein sources:

  • Vegetables provide essential nutrients and antioxidants for healing, and fiber for balancing the gut microbiome.
  • Healthy fats reduce brain inflammation. These include the monounsaturated fatty acids in natural sources like olive oil and avocados, and omega-3 fatty acids from fish.
  • Inflammatory foods, such as food products derived from corn and wheat, and corn-fed beef and pork, should be strictly avoided.
  • Optimal sources of protein include fish, eggs, and poultry. Eggs in particular are rich in choline and other essential brain nutrients. If you’re seeking vegan protein sources, quinoa, peas, and hemp are good alternatives.
  • Following a strict ketogenic diet has been shown to benefit recovery from neuroinflammatory conditions. That means keeping your carbohydrate intake low enough to cause brain cells and other tissues to switch from burning glucose to burning ketones. Admittedly, however, strict ketogenic diets are challenging to stick to consistently.

Beyond eating fresh fish regularly, supplementing with omega-3 fatty acids has been widely studied for reducing inflammation in both acute and chronic neuroinflammatory illness. Krill oil and fish oil are optimal sources of the DHA and EPA omega-3 fatty acids necessary for brain health. To determine your optimal dosing levels, consider doing periodic blood testing for omega fatty acid balance; test kits can be bought online for approximately $100.

Herbs are ideal for reducing systemic and neuroinflammation. They work by balancing your immune response instead of suppressing it, and directly inhibit tissue inflammation in the brain and nervous system. Anti-inflammatory herbs also promote optimal blood flow to the brain and tissues by enhancing vascular system function. Some of the best choices include turmeric, boswellia, resveratrol from Japanese knotweed, and French maritime pine bark.

Cannabidiol (CBD), a cannabinoid found in the hemp variety of cannabis, has shown great promise for reducing neuroinflammation and calming nerve irritability, reducing pain, enhancing mood, and promoting normal sleep. Cannabinoids also balance immune functions.

CBD from hemp is legal in all fifty states and can be shipped across state lines. It does not contain THC, the psychoactive substance in marijuana. CBD oil is the optimal form for delivery and absorption. Average dose is 20-50mg of CBD with mixed cannabinoids; look for products with 1500 mg per fluid oz.

Finally, essential oils are excellent for reducing brain inflammation. They contain primarily fat soluble phytochemicals of herbs — ideal for penetrating brain and nerve tissue, which is 60% fat. Good essential oil choices for neuroinflammation include rosemary, oregano, frankincense, lavender, and lemon balm — the latter three also support normal sleep. Aromatherapy (olfactory delivery) is the most direct way to administer the phytochemicals of essential oils to the brain and nervous system.

2. Purify your system of toxins

A toxic environment impedes recovery from any illness. And unfortunately, chronic systemic inflammation and neurological inflammation can compromise detoxification and waste removal processes in the brain and body even further.

Toxic substances can enter the body by three routes — oral, respiration, and skin — so step one is minimizing the inflow. To reduce oral toxins, avoid processed food products, and eat a fresh, whole food diet weighted toward vegetables (the fiber in veggies enhances detoxification). Clean water is also key, and is as simple as installing a water filter.

Regularly changing your HVAC air filters and placing free-standing HEPA filters in rooms where you spend the majority of your time can go a long way toward improving indoor air quality. Breathing fresh air in natural places as often as possible can also promote healing.

As for your skin, adopting a practice of using only natural skin care products allows you to avoid a surprising number of toxic substances commonly found in commercial skin care products. The same goes for household cleaning supplies. The Environmental Working Group is a great resource for finding toxin-free consumer products.

Supplements that support detoxification in the body include activated B vitamins for enhanced methylation (a metabolic process that’s vital to cellular health), and glutathione, NAC, and alpha lipoic acid to support cellular functions and detoxification. Dandelion and milk thistle protect the liver and stimulate bile flow, which is essential for removing toxic substances from the body.

Optimal levels of vitamin D are also important for recovery, as are zinc and magnesium. Magnesium is best taken as magnesium glycinate, which is calming and easy on the digestive tract.

You might also consider hyperbaric oxygen therapy, a treatment that involves breathing 100% oxygen inside a body chamber with low and controlled atmospheric pressure. This therapy was found to be valuable in the Sears-Bailes protocol for overcoming traumatic brain injury, and has also been shown to be beneficial for Lyme disease recovery.

3. Invite more calm into your life

Since stress is a powerful immune system disruptor, finding more calm is key to restoring immune health and resolving symptoms of neurological Lyme. One of the best tools to fight stress is getting optimal sleep. Without it, your immune functions are disrupted, and healing is compromised.

Sleep is especially important for recovery from neuroinflammatory illnesses. Studies have shown that even one night of compromised sleep in healthy people is associated with accumulation of beta amyloid in the brain, a hallmark of Alzheimer’s disease.

Your goal: At least 8 hours of good sleep a night, including 4 hours of deep sleep. Practicing good sleep hygiene can help you hit the mark; that includes keeping a regular bedtime, and limiting light, computer screens, and stimulation in the evening.

What happens during the day is also key to drifting off at night. Finding additional ways to de-stress, getting regular low-intensity exercise, and practicing meditation a couple of times during the day promotes good sleep onset and better quality sleep at night.

Early on, when neuroinflammation is pronounced and the nervous system is very agitated, sleep medications may be indicated. But use them intermittently, and stick to the lowest dose possible.

If you’re still battling stress and occasional sleeplessness, herbs can help. Some with calming, neuroprotective properties include ashwagandha, bacopa, gotu kola, kudzu, and milky oat seed. Nervine herbs also promote calm during the day and help improve sleep at night; these include passionflower, motherwort, lemon balm, and chamomile.

Melatonin, an important antioxidant in the brain that initiates sleep, is reduced in neuroinflammation. Supplemental melatonin at bedtime (1-3 mg) can help rebalance disrupted sleep pathways. Tart cherry juice is an excellent natural source of melatonin, as is Chinese skullcap, an herb providing both antimicrobial properties and immune balancing properties.

Acupuncture can be beneficial for reducing pain and restoring normal energy pathways in the body. It is also helpful for restoring normal sleep.

4. Get active

Healthy blood flow is essential for recovery. Increased blood flow flushes out toxic substances that have accumulated from inflammation, and stimulates healing systems in the body.

The best way to increase blood flow is by moving your body. Increased activity is associated with increased endorphins. Best known as the “feel good” substances that improve mood and wellbeing, endorphins also stimulate natural killer cells, the most important white blood cells for taking out cells infected with microbes.

That being said, movement must be balanced so as to not generate more inflammation. For this purpose, low intensity exercise such as walking, yoga, and tai chi is the best choice. If exercise is not practical, far infrared sauna is an ideal way to increase blood flow and promote removal of toxins from the body.

5. Balance the microbiome

Restoring normal immune function and balancing the microbiome of the body is the most important part of overcoming neuroinflammatory conditions. It includes suppressing opportunistic microbes while also allowing normal flora to flourish so that immune systems can rebound.

For this purpose, herbal therapy is a natural fit. Herbs with antimicrobial properties selectively suppress opportunistic and stealth microbes without disturbing normal flora. Herbs also help boost parts of the immune system that have been suppressed by the microbes. Many of the chemical components of herbs cross the blood-brain barrier and provide neuroprotective benefits. By restoring balance in the gut microbiome and the extended microbiome of the body, the gut-blood and blood-brain barriers are allowed to heal.

There are many herbs with antimicrobial properties that can provide benefit for neuroinflammation associated with microbiome disruption. Some of the more common ones used in Lyme disease include andrographis, cat’s claw, Japanese knotweed, cryptolepis, and neem. Monolaurin is a fatty extract from coconut that provides antimicrobial properties, and because it is fat soluble, it easily crosses the blood-brain barrier and penetrates into brain tissues.

Berberine and berberine-containing herbs, including coptis, goldenseal, and barberry, are ideal for balancing the gut microbiome and restoring a normal gut-blood barrier. Sarsaparilla is another antimicrobial herb that is particularly good for balancing the gut microbiome.

Herbs that boost the immune system’s ability to control stealth microbes and restore normal immune system functions, but at the same time reduce inflammation, are called immunomodulating herbs. Immunomodulating herbs that also provide neuroprotective benefits include cordyceps, reishi, rhodiola, and eleuthero. These herbs are also adaptogens, herbs that improve stamina and resistance to stress without having drug-like effects.

Because the toxicity of most commonly used herbs is so low, herbs can be taken for extended periods of time without harmful effects. In fact, that’s exactly what it takes to wear down stealth microbes and other opportunists, and allow normal flora to flourish.

The neurological system takes a long time to heal — it’s not a game that’s won in weeks or even months. Patience and persistence for the long haul is required to regain wellness. Many people have found, however, that persistence pays off: A comprehensive, natural approach to recovery is the most secure way to win.

 Dr. Rawls is a physician who overcame Lyme disease through natural herbal therapy. You can learn more about Lyme disease and recovery in Dr. Rawls’ best-selling book, Unlocking Lyme.

You can also learn about Dr. Rawls’ personal journey in overcoming Lyme disease and fibromyalgia in his popular blog post, My Chronic Lyme Journey.

REFERENCES
1. https://www.cdc.gov/lyme/index.html
2. Geeta Ramesh et. al. Inflammation in the Pathogenesis of Lyme Neuroborreliosis. Am J Pathol. 2015 May; 185(5): 1344–1360.
3. Forrester JD et. al. No Geographic Correlation between Lyme Disease and Death Due to 4 Neurodegenerative Disorders. Emerg Infect Dis. 2015 Nov;21(11):2036-9.
4. Clark K et. al. Lyme borreliosis in human patients in Florida and Georgia. Int J Med Sci. 2013 May 23;10(7):915-31.
5. Batinac T et. al. Lyme borreliosis and multiple sclerosis are associated with primary effusion lymphoma. Med Hypotheses. 2007 Jan 2;69(1):117-9.
6. Tsiodras S et. al.Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect. 2005 Dec;51(5):343-54.
7. Tsai CS et. al. The association between Mycoplasma pneumoniae infection and speech and language impairment: A nationwide population-based study in Taiwan. PLoS One. 2017 Jul 3;12(7).
8. Panagariya A et al. Reversible neurological syndromes with atypical pneumonia. Ann Indian Acad Neurol. 2011 Apr;14(2):127-9.
9. Kaufman DL et. al. Neurological and immunological dysfunction in two patients with Bartonella henselae bacteremia. Clin Case Rep. 2017 Apr;5(6):931-935.
10. Mayne PJ. Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohort. Int J Gen Med. 2014 Dec 23;8:15-26.
11. Breitschwerdt EB et. al. Bartonella vinsonii subsp. berkhoffii and Bartonella henselae bacteremia in a father and daughter with neurological disease. Parasit Vectors. 2010 Apr 8;3(1):29.
12. Usmani-Brown S et. al. Neurological manifestations of human babesiosis. Handb Clin Neurol. 2013;114:199-203.
13. Salva I et. al. Rickettsial meningitis. BMJ Case Rep. 2014 Mar 10.
14. Hongo I et. al. Ehrlichia infection of the central nervous system. Curr Treat Options Neurol. 2006 May;8(3):179-84.
15. Hassani A et. al. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS One. 2018 Feb 2;13(2).
16. Leibovitch E et. al. Viruses in chronic progressive neurologic disease. Mult Scler. 2018 Jan;24(1):48-52.
17. Emery DC et. al. 16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer’s Post-Mortem Brain. Front Aging Neurosci. 2017 Jun 20;9:195.
18. Branton W et. al. Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis. Sci Rep. 2016 Nov 28;6:37344.
19. Cadavid D et. al. Antibiotics for the neurological complications of Lyme disease. Cochrane Database Syst Rev. 2016 Dec 8.
20. Halperin JJ. Chronic Lyme disease: misconceptions and challenges for patient management. Infect Drug Resist. 2015 May 15;8:119-28.
21. Shokri-Kojori E et. al. β-Amyloid accumulation in the human brain after one night of sleep deprivation. PNAS. 2018 Apr 9.
22. Sugeno N et. al. A case with anti-galactocerebroside antibody-positive Mycoplasma pneumoniae meningoencephalitis presenting secondary hypersomnia. Neurol Sci. 2012 Dec;33(6):1473-6.
23. Neal W et. al. The role of primary infection of Schwann cells in the aetiology of infective inflammatory neuropathies. J Infect. 2016 Nov;73(5):402-418.
24. Colonna M et. el. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017 Apr 26;35:441-468.
25. Obermeier B et. al. The blood-brain barrier. Handb Clin Neurol. 2016;133:39-59.
26. Fung TC et. al. Interactions between the microbiota, immune and nervous systems in health and disease.
Nat Neurosci. 2017 Feb;20(2):145-155.
27. Layé S et. al. Anti-Inflammatory Effects of Omega-3 Fatty Acids in the Brain: Physiological Mechanisms and Relevance to Pharmacology. Pharmacol Rev. 2018 Jan;70(1):12-38.
28. Devassy JG et al. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. Adv Nutr. 2016 Sep 15;7(5):905-16.
29. McDougle DR et. al. Anti-inflammatory ω-3 endocannabinoid epoxides. Proc Natl Acad Sci. 2017 Jul 25;114(30):E6034-E6043. doi: 10.1073/pnas.1610325114. Epub 2017 Jul 7.
30. Rudroff T et. al. Cannabidiol to Improve Mobility in People with Multiple Sclerosis. Front Neurol. 2018 Mar 22;9:183.
31. Petrosino S et. al. Anti-inflammatory properties of cannabidiol, a non-psychotropic cannabinoid, in experimental allergic contact dermatitis. J Pharmacol Exp Ther. 2018 Apr 9.
32. Mori MA et. al. Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:94-105.
33. Richer A. Functional Medicine Approach to Traumatic Brain Injury. Med Acupunct. 2017 Aug 1; 29(4): 206–214.

 

Coinfection Webinar: April 18, 2018

https://rawlsmd.com/webinars/ask-dr-rawls/?utm_campaign=webinar+_hash_19+-+ask+dr.+rawls+live+lyme+q%26a+-+4.18.18+-

c885a9ef-ask-dr-rawls-logo-03_0f10970f0097000000

No questions about Lyme disease coinfections are off the table. Please feel free to ask common or uncommon questions, such as:

• What are telltale signs of a coinfection? • Which herbs are most helpful for overcoming coinfections? • Should you treat coinfections before addressing Lyme?  • What is the best treatment for coinfections?  • Is it possible to ever cure Lyme and its coinfections?  • Are all coinfections transmitted by ticks?  • How can you tell for sure when Lyme and coinfections are gone?  • How does treatment and diet for Lyme differ if you have a coinfection?  • How long will it take to feel good again?

RESERVE MY SEAT »

Ask Dr. Rawls, Live Q&A Webinar